Rhei Rhizoma ("Dahuang" in Chinese) has been used for the treatment of constipation and various syndromes caused by the obstruction of blood circulation, such as dysmenorrhea, etc. in traditional Chinese medicine.
Rhei Rhizoma ("Dahuang" in Chinese) has been used for the treatment of constipation and various syndromes caused by the obstruction of blood circulation, such as dysmenorrhea, etc. in traditional Chinese medicine. 1, 2) Its pharmacological effects have been known to be variable according to its botanic origin and the composition of its chemical constituents. 3, 4) In the Japanese Pharmacopoeia, 5) Rhei Rhizoma is prescribed as Rheum palmatum, R. tanguticum, R. officinale, and R. coreanum of section Palmata, family Polygonaceae, 6) while the first three species are prescribed as Dahuang in the Chinese Pharmacopoeia. 1) However, due to the morphologic similarity of the aerial parts and frequent occurrence of intermediate forms, the taxonomy of this genus and the correct identification of Rheum species and Rhei Rhizoma are very difficult. Recently, DNA-based polymorphic assay was found to provide valuable information necessary to resolve such taxonomic problems. [7] [8] [9] The chloroplast matK gene sequence has been widely employed as a powerful tool in examining inter-and intragenus phylogeny due to its high substitution rate. [10] [11] [12] In our previous paper, 13) molecular analysis of the matK gene sequences of 56 plant specimens of nine Rheum species, especially of 47 specimens of the above three species used as the official Dahuang in China (Table 1) , was performed to clarify their phylogenetic relationship and to determine the identification markers of the three species. Although the matK gene sequence of genus Curcuma of family Zingiberaceae was quite conservative intragenus, 8) and that of genus Panax of family Araliaceae was stable intraspecies, 9) those of the three Rheum species were variable not only interspecies but also intraspecies (Table 2) . However, the phylogenetic tree constructed using the unweighted pair group method with arithmetic mean (UPGMA method) showed that the specimens of R. tanguticum and those of R. officinale belonged to their own subclades, respectively, while those of R. palmatum belonged to the three subclades related to their production areas. The result of sequence comparison of the matK gene revealed that the key nucleotides for identifying section Palmata, including official species, existed at positions 587, 707, and 838, and the marker nucleotides for identifying three official species such as R. palmatum, R. tanguticum and R. officinale were at 367 and 937, while those for distinguishing the three intraspecies groups of R. palmatum were at 619, 769, 883, and 1061. In the present paper, based on the above marker nucleotides, polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) 14, 15) and amplification refractory mutation system (ARMS) [14] [15] [16] analyses were designed in order to develop a convenient and efficient identification method for Rhei Rhizoma. On the matK gene sequence, we found restriction enzyme sites detecting three marker nucleotides, one at position 587 which is useful for identifying section Palmata, and another two at positions 769 and 1061 for distinguishing the three groups of R. palmatum (Fig. 1 ). For these two purposes, PCR-RFLP analysis was carried out. On the other hand, for the purpose of identification of R. palmatum, R. tanguticum and R. officinale, ARMS analysis using three sets of designed primers 17, 18) was performed. After PCR-RFLP and ARMS methods were established using plant specimens of eight Rheum species, their application for the identification of Rhei Rhizoma was investigated.
MATERIALS AND METHODS
Materials Forty-seven plant specimens of R. palmatum, R. tanguticum and R. officinale, and eight specimens of R. rhaponticum, R. franzenbachii, R. undulatum, R. przewalskyi and R. kialense were used in this study (Table 1) . Twenty-two drug samples of Rhei Rhizoma (Dahuang) were purchased from Chinese markets near the fields of Rheum species, and from Uchida Wakanyaku Co., Ltd. (Tokyo, Japan) and Tochimoto Tenkaido Co., Ltd. (Osaka, Japan) ( Table 3 ). Both plant specimens and drug samples are deposited in the Museum of Materia Medica, Institute of Natural Medicine, Toyama Med-ical and Pharmaceutical University (TMPW).
Total DNA Preparation Total DNA was extracted from 50-100 mg of dried or fresh leaves of the plant specimens using the DNeasy TM Plant Mini Kit (QIAGEN, Germany), and from 100-1000 mg of drug samples using the CTAB method described in our previous paper.
15)
PCR-RFLP Analysis PCR amplification of the partial matK gene was performed using 10-100 ng of total DNA as a template in 50 ml of reaction mixture, consisting of 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.1% Triton X-100, 1.5 mM 
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Vol. 27, No. 5 agarose gel electrophoresis and visualized by ethidium bromide staining under UV. In the case of one drug sample (Table 3: D21) , as a PCR product of the partial matK gene was not obtained, two regions (1 and 2) were amplified separately using matK191F and trnK1544R, and matK646F and matK8R, respectively, together with the total DNA as a template (Fig. 1) . The cycling condition was the same as mentioned above except for the annealing temperature being adjusted to 53°C. The PCR product of region 1 was digested with restriction enzyme BglII, whereas that of region 2 was digested with restriction enzymes NsiI or DraI. ARMS Analysis On the basis of the nucleotide substitutions at positions 367 and 937 among the three official species on the matK gene, at each position two kinds of reverse primers, matK367CR and matK367TR, and matK937CR and matK937TR with complementary 3Ј-terminal nucleotide were designed ( Table 4 , Fig. 1 ). To enhance the specificity, a destabilizing mismatch was incorporated at the 3rd nucleotide from the 3Ј terminus in each reverse primer. 17, 18) Three sets of primers ( Fig. 3: A, B and C) were prepared, each of which consisted of 2 kinds of reverse primers, matK367CR or matK367TR, and matK937CR or matK937TR, and one forward primer, matK191F. For each primer set, the PCR amplification was performed using total DNAs from all materials as a template in 25 ml of reaction mixture composed of 10 mM Tris-HCl (pH 9.0), 50 mM KCl, 0.1% Triton X-100, 1.5 mM MgCl 2 , 0.2 mM of each dNTP, 0.25 mM of forward primer, 0.125 mM of each reverse primer and 1.5 U Taq Polymerase (Promega, U.S.A.). The optimal cycling condition for primer set A was established as follows: hot start at 94°C for 1 min, followed by 40 cycles at 94°C for 1 min, 52°C for 1 min, 72°C for 2 min, and a final extension at 72°C for 15 min. For primer sets B and C, the annealing temperature and time were changed to 59°C for 50 s and 58.5°C for 50 s, respectively, and the extension time was also changed to 1 min and 50 s. The 5 ml of resulting product was analyzed by 2.0% agarose gel electrophoresis.
RESULTS

Determination of Rheum Species Officially Used as Rhei Rhizoma
The PCR products of six Rheum species amplified with a pair of primers, matK191F and matK8R, were of 1129 bp in length, except for those of R. przewalskyi and R. kialense of 1135 bp. The restriction enzyme BglII, which recognizes the sequence of 5ЈAGATCT3Ј, was found to give diagnostic fragments among the eight species. The matK gene of five species, excluding the three official species, had a BglII restriction site at the nucleotide position 586-591 (Fig. 2A) . The PCR products of these five species digested with BglII showed three fragments of 100, 296 and 733 or 739 bp, while in the three official species the products showed two fragments of 100 and 1029 bp in electrophoretogram (Fig. 2B 1 ) .
Identification of Three Rheum Species Upon PCR amplification using three sets of primers (A, B and C), each consisting of 2 kinds of reverse primers, matK367CR or matK367TR and matK937TR or matK937CR, and one forward primer, matK191F, and template DNA from each species, one or two fragments of 202 bp and/or 770 bp in length or no fragments were observed in the electrophoretogram. When the primer set A was used, one fragment of 202 bp was observed in R. palmatum, one fragment of 770 bp in R. tanguticum, and both fragments in R. officinale (Fig.  3A 1 ). When the primer set B was used, two fragments of 202 and 770 bp were observed in R. palmatum, one fragment of 202 bp in R. officinale, and no fragments in R. tanguticum (Fig. 3A 2 ) . When primer set C was used, two fragments were observed in R. tanguticum, one fragment of 770 bp in R. officinale, and no fragments in R. palmatum (Fig. 3A 3 ) . By observing three kinds of fragment profiles, the three official species were authenticated.
Distinction of the Three Groups of Rheum palmatum The restriction enzymes NsiI and DraI, which recognize the sequence of 5ЈATGCAT3Ј and that of 5ЈTTTAAA3Ј, respectively, were found to give diagnostic fragments among the three groups of R. palmatum (I, II, III). The matK gene of groups I and II had a NsiI restriction site at the nucleotide position 1058-1063; moreover, that of group I had a DraI restriction site at the position 768-773 (Fig. 4A, C) . The PCR products of groups I and II digested with NsiI showed two fragments of 263 and 866 bp, whereas that of group III showed one fragment of 1129 bp (Fig. 4B 1 ) . On the other hand, the digestion of the PCR products with DraI resulted in the formation of three fragments of 247, 333 and 549 bp in group I, and two fragments of 247 and 882 bp in group II (Fig. 4D 1 ) .
Identification of Rhei Rhizoma Twenty-two drug samples (Table 3) were analyzed by using the above PCR-RFLP and ARMS methods. Their PCR products, amplified with a pair of primers, matK191F and matK8R, in a semi-nested PCR method, were of 1129 bp in length except for one sample (D21) with no product. The digestion of the PCR products with the restriction enzyme BglII resulted in the formation of two fragments of 100 and 1029 bp (Fig. 2B 2 ) , suggesting that the 21 samples were derived from official Rheum species of section Palmata. In the ARMS method using three sets of primers, six drug samples from Qinghai Province showed the same fragment patterns as those of R. tanguticum (Fig. 3B : D11, D14 and D22), one sample from Wanyuan County, Sichuan Province, as those of R. officinale (D4), and the remnants, as those of R. palmatum, respectively. As for the last 14 samples, their PCR products were digested with the restriction enzyme NsiI or DraI. The PCR products of 5 drug samples, mostly from Sichuan Province, digested with NsiI showed one fragment ( Fig. 4B 2 : D17, D20 and D9), whereas those of the other 9 samples showed two fragments, which suggested that the former was originated from group III and the latter from groups I or II of R. palmatum, respectively. The digestion of the PCR products of the latter samples with DraI resulted in the formation of three fragments in 2 samples from Banma County, Qinghai Province and Ganzi County, Sichuan Province ( Fig. 4D 2 : D1 and D15), and two fragments in 7 samples from mostly Gansu and Yunnan Provinces, suggesting that the former was originated from group I and the latter from group II of R. palmatum, respectively.
Identification of One Drug Sample (D21) Upon PCR amplification of regions 1 and 2 of the partial matK gene (Fig. 1) , the PCR products of 612 and 674 bp were obtained, respectively. The PCR product of region 1 digested with BglII showed two fragments of 100 and 512 bp, which was the same as in the three official Rheum species (Fig. 5A) . The result of ARMS analysis suggested that this sample was derived from R. palmatum (Fig. 3B) . Then, the PCR product of region 2 was digested with NsiI or DraI. Two fragments of 263 and 411 bp and those of 125 and 549 bp were observed in the digestion with NsiI and DraI, respectively, which were the same as in group I of R. palmatum (Fig. 5B, C) .
DISCUSSION
Previously, 13) we investigated the phylogenetic relationship of the Rheum species, especially of R. palmatum, R. tanguticum and R. officinale of section Palmata, used as Rhei Rhizoma officially on the basis of their matK gene sequences. The phylogenetic tree suggested that R. tanguticum and R. officinale were monophyletic, but R. palmatum was mainly composed of 3 groups (I, II, III) which were related to the production area. In general, specimens from the southeast part of Qinghai Province and northwestern part of Sichuan Province belonged to group I, those from Gansu Province to group II, and those from the central to southern part of Sichuan Province to group III, respectively. By sequence comparison, we also have determined marker nucleotides to identify section Palmata, to identify the above three official species, and to distinguish the three intraspecies groups of R. palmatum. In the present study, on the basis of five marker nucleotides at positions 367, 587, 769, 937 and 1061, PCR-RFLP and ARMS analyses were designed. PCR-RFLP methods using restriction enzymes BglII, and NsiI or DraI were developed for identifying section Palmata and for identifying the three groups of R. palmatum, respectively. For the identification of three official species, ARMS method was developed using three sets of primers, each having two kinds of species-specific reverse primers designed on the basis of nucleotide differences at positions 367 and 937. The plant specimens were analyzed using the PCR-RFLP and ARMS methods to give the expected products in an electrophoretogram. For the plant specimen identified as group I of R. palmatum, two fragments were observed in the digestion of the PCR product with BglII; both 202 and 770 bp fragments were detected in the ARMS method using primer set B; and two and three fragments were observed in the digestion of the PCR product with NsiI and DraI, respectively. These methods were also applied to drug samples of Rhei Rhizoma. The ARMS method was found to be valuable in identifying the species of the drug samples. However, the PCR-RFLP method failed at first in most samples, since PCR products of the partial matK gene were not detected. When a semi-nested PCR method was performed using these PCR products as a template, the expected products were obtained except for one sample (D21). As for this sample, upon PCR amplification of dividing two regions of the partial matK gene, PCR products of 612 and 674 bp were obtained, respectively. It was understood that a semi-nested PCR method was required to obtain PCR products from drug samples, and a region shorter than 700 bp was suitable for amplification. After obtaining the PCR products, using the PCR-RFLP method, the groups of R. palmatum were identified.
Adding to the 10 drug samples investigated in our previous paper, we investigated 12 more samples to identify their botanic origins by using PCR-RFLP and ARMS methods. Thereafter, six out of the 12 samples were selected to determine the partial matK gene sequences to validate the accuracy of the identification, then sequencing results were found to be completely consistent with those demonstrated in our present method. All 22 samples were found to be derived from official Rheum species. Their botanic origins almost corresponded with those deduced from information about their production areas, as previously described. However, two drug samples (D18 and D19) from Wanyuan County, Sichuan Province were found to be derived from group II of R. palmatum, not as expected from R. officinale. 19) Although most Rhei Rhizoma derived from group II of R. palmatum is produced in Gansu Province, these samples were thought to be produced in Sichuan Province, since the partial matK gene sequence was identical to that of the plant specimen from Sichuan Province ( Table 2 : Ps4). On the other hand, one drug sample named "Ya-huang" (D21), which is available in the Japanese market, was found to be derived from group I of R. palmatum, not as expected from group III. 13) Although the Ya-huang samples imported from China have been known to be produced in Jiulong and Shimian Counties, the central part of Sichuan Province, 5, 20) their production areas have been moved recently to the northwestern part. In fact, the partial matK gene sequence was found to be identical to that of wild plants from Xinlong County, in the northwestern part of Sichuan Province (Table 2: Ps15).
In the present study, the PCR-RFLP and ARMS methods were established as convenient tools for identifying Rhei Rhizoma derived from Rheum species. After obtaining 2 kinds of PCR products from dividing two regions of partial matK gene, the combination of PCR-RFLP and ARMS are thought to be useful for identifying drug samples. Also, the matK gene sequences of drug samples are expected to become useful indices for quality control of Rhei Rhizoma, and for predicting their production areas.
After the origins of Rhei Rhizoma were unambiguously authenticated by molecular analysis, evaluation of their quality based on chemical components will be reported in the forthcoming article. A) PCR products of region 1 (612 bp), amplified using DNAs from eight Rheum species (three official and five unofficial species) and one drug sample as a template, were digested with BglII. (B) and (C) PCR products of region 2 (674 bp) were amplified using DNAs from three groups of R. palmatum, and one drug sample as template, were digested with NsiI (B) or DraI (C). 1, restriction sites of BglII, NsiI or DraI; 2, agarose gel electrophoretograms of the PCR products digested with three restriction enzymes; nucleotides with shadows indicate the defined identification markers at position 587 (A), 1061 (B) or 769 (C). Lane M, 1 kb DNA ladder; MЈ, pBR 322DNA-MspI digestion.
